These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 20012145)
21. Unveiling autonomic failure in synucleinopathies: Significance in diagnosis and treatment. Clement G; Cavillon G; Vuillier F; Bouhaddi M; Béreau M Rev Neurol (Paris); 2024; 180(1-2):79-93. PubMed ID: 38216420 [TBL] [Abstract][Full Text] [Related]
22. Characterization of the symptoms of neurogenic orthostatic hypotension and their impact from a survey of patients and caregivers. Claassen DO; Adler CH; Hewitt LA; Gibbons C BMC Neurol; 2018 Aug; 18(1):125. PubMed ID: 30144800 [TBL] [Abstract][Full Text] [Related]
23. Abnormalities of rate-corrected QT intervals in Parkinson's disease-a comparison with multiple system atrophy and progressive supranuclear palsy. Deguchi K; Sasaki I; Tsukaguchi M; Kamoda M; Touge T; Takeuchi H; Kuriyama S J Neurol Sci; 2002 Jul; 199(1-2):31-7. PubMed ID: 12084439 [TBL] [Abstract][Full Text] [Related]
24. Long-term trends in myocardial sympathetic innervation and function in synucleinopathies. Lamotte G; Holmes C; Wu T; Goldstein DS Parkinsonism Relat Disord; 2019 Oct; 67():27-33. PubMed ID: 31621602 [TBL] [Abstract][Full Text] [Related]
25. Neurogenic orthostatic hypotension in Parkinson's disease: evaluation, management, and emerging role of droxidopa. Isaacson SH; Skettini J Vasc Health Risk Manag; 2014; 10():169-76. PubMed ID: 24729712 [TBL] [Abstract][Full Text] [Related]
26. Longitudinal prevalence of neurogenic orthostatic hypotension in the idiopathic Parkinson Progression Marker Initiative (PPMI) cohort. Beach P; McKay JL Auton Neurosci; 2024 Jun; 253():103173. PubMed ID: 38692034 [TBL] [Abstract][Full Text] [Related]
27. Predictors of the Pressor Response to the Norepinephrine Transporter Inhibitor, Atomoxetine, in Neurogenic Orthostatic Hypotension. Shibao CA; Palma JA; Celedonio JE; Martinez J; Kaufmann H; Biaggioni I Hypertension; 2021 Aug; 78(2):525-531. PubMed ID: 34176285 [TBL] [Abstract][Full Text] [Related]
28. [Orthostatic hypotension and supine hypertension in primary autonomic failure. Pathophysiology, diagnosis and treatment]. Tykocki T; Guzek K; Nauman P Kardiol Pol; 2010 Sep; 68(9):1057-63. PubMed ID: 20859904 [TBL] [Abstract][Full Text] [Related]
29. Characteristics of orthostatic hypotension in Parkinson's disease. Oka H; Yoshioka M; Onouchi K; Morita M; Mochio S; Suzuki M; Hirai T; Ito Y; Inoue K Brain; 2007 Sep; 130(Pt 9):2425-32. PubMed ID: 17673498 [TBL] [Abstract][Full Text] [Related]
33. Validation of the new index of baroreflex function to identify neurogenic orthostatic hypotension. Guaraldi P; Baschieri F; Barletta G; Cecere A; Cortelli P; Calandra-Buonaura G Auton Neurosci; 2020 Dec; 229():102744. PubMed ID: 33189018 [TBL] [Abstract][Full Text] [Related]
34. The effects of water ingestion on orthostatic hypotension in two groups of chronic autonomic failure: multiple system atrophy and pure autonomic failure. Young TM; Mathias CJ J Neurol Neurosurg Psychiatry; 2004 Dec; 75(12):1737-41. PubMed ID: 15548493 [TBL] [Abstract][Full Text] [Related]
35. Orthostatic Hypotension: JACC State-of-the-Art Review. Freeman R; Abuzinadah AR; Gibbons C; Jones P; Miglis MG; Sinn DI J Am Coll Cardiol; 2018 Sep; 72(11):1294-1309. PubMed ID: 30190008 [TBL] [Abstract][Full Text] [Related]
36. Neurogenic hyperadrenergic orthostatic hypotension: a newly recognized variant of orthostatic hypotension in older adults with elevated norepinephrine (noradrenaline). Mar PL; Shibao CA; Garland EM; Black BK; Biaggioni I; Diedrich A; Paranjape SY; Robertson D; Raj SR Clin Sci (Lond); 2015 Jul; 129(2):107-16. PubMed ID: 25706983 [TBL] [Abstract][Full Text] [Related]
37. Autonomic innervation in multiple system atrophy and pure autonomic failure. Donadio V; Cortelli P; Elam M; Di Stasi V; Montagna P; Holmberg B; Giannoccaro MP; Bugiardini E; Avoni P; Baruzzi A; Liguori R J Neurol Neurosurg Psychiatry; 2010 Dec; 81(12):1327-35. PubMed ID: 20660924 [TBL] [Abstract][Full Text] [Related]
38. L-threo-dihydroxyphenylserine (L-threo-DOPS; droxidopa) in the management of neurogenic orthostatic hypotension: a multi-national, multi-center, dose-ranging study in multiple system atrophy and pure autonomic failure. Mathias CJ; Senard JM; Braune S; Watson L; Aragishi A; Keeling JE; Taylor MD Clin Auton Res; 2001 Aug; 11(4):235-42. PubMed ID: 11710796 [TBL] [Abstract][Full Text] [Related]